Héctor Armengod, Vice Chair of the Global Antitrust & Competition Practice, helps clients secure antitrust clearances for their transformational deals before regulators in the EU and globally.

Leveraging over two decades of experience, Héctor combines deep industry knowledge with a unique understanding of the global antitrust landscape to help clients navigate:

  • Merger control proceedings before the European Commission, and other antitrust regulators globally 
  • European Commission cartel and Article 102 TFEU investigations
  • Complex licensing, joint venture, distribution, co-promotion, co-marketing, and co-operation agreements in the context of competition law

He regularly guides clients on their largest and most complex strategic mergers, which typically require merger clearances in the EU and in multiple jurisdictions globally. Héctor’s expertise cuts across sectors, with a particular focus on life sciences, media and entertainment, automotive, industrial, and consumer products, and business services. 

Before joining Latham, Héctor worked as competition lawyer at another international law firm in Brussels and in the Brussels and Madrid offices of a Spanish law firm. He gained insight into the workings of the European Commission during an internship with the Competition Directorate General of the European Commission.

Héctor's experience includes representing:

Life Sciences

  • Abcam in its US$5.7 billion sale to Danaher 
  • Nordic Capital in its sale of The Binding Site to Thermo Fisher 
  • Cerner in its US$28.3 billion sale to Oracle 
  • Siemens Healthineers in its US$16.4 billion acquisition of Varian Medical System (conditional Phase I EU clearance)
  • Syneos Health in its US$7.1 billion sale to a consortium of private investment firms 
  • Integra in its acquisition of J&J’s Codman Neuro Division 
  • Acino in its acquisition of Takeda’s EMEA primary care portfolio 
  • Eli Lilly in its acquisitions of:
    • Novartis’ Animal Health Business 
    • Janssen Pharmaceutical’s Animal Health Business  
    • Certain animal health assets from Pfizer, which had to divested as a result of Pfizer’s merger with Wyeth 
  • Archimed in the acquisition of Natus Medical
  • Actavis’ acquisition of Warner Chilcott
  • ERT in its merger with Bioclinica
  • ICU Medical in the acquisition of Pfizer's Hospira Infusion Systems business
  • Altaris Capital Partners in the sale of BK Medical to GE Healthcare

Entertainment and Media

  • Live Nation in its:
    • Acquisition of control over Altice Arena in Portugal 
    • Acquisition of MCD (unconditional Phase II clearance in UK and conditional Phase II clearance in Ireland)
    • US$2.5 billion acquisition of Ticketmaster
  • Omnicom in its:
    • Acquisition of Flywheel Digital
    • Planned merger with Publicis 

Industrial and Automotive

  • Novelis in its US$2.6 billion acquisition of rival Aleris (conditional Phase II clearance in the EU)
  • One Rock Capital in its US$2 billion acquisition of Constantia Flexibles 
  • Tenneco in its US$7.1 billion sale to Apollo Global Management 
  • GCP Applied Technologies in its US$2.3 billion sale to Saint-Gobain 
  • Hyundai in the creation of its autonomous driving vehicle JV with APTIV 
  • Nissan Motor in its acquisition of control over Mitsubishi Motors 
  • Siemens in its acquisition of Dresser Rand (unconditional clearance in Phase II in the EU) 
  • Veyance Technologies in its acquisition by Continental 
  • Eaton in its acquisition of Cooper Industries 

Consumer Products and Business Services

  • Aon in its planned US$30 billion acquisition of Willis Towers Watson (conditional Phase II clearance in EU)
  • Multinational luxury fashion company Tapestry in its planned US$8.5 billion acquisition of Capri Holdings, owner of luxury fashion brands Versace, Michael Kors, and Jimmy Choo 
  • Authentic Brands Group in its acquisition of the Reebok, Boardriders, and Champion brands 

Bar Qualification

  • Brussels Bar - E List
  • Spain (Abogado)

Education

  • LL.M. (European Union Law), Leiden Law School (Netherlands), 2000
  • Law Degree, Universidad de Deusto, 1999

Languages Spoken

  • English
  • German
  • Spanish